|
KDELR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.434030E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.897740E-03 |
| Normal-vs-Stage2 |
7.998600E-01 |
| Normal-vs-Stage3 |
3.643000E-01 |
| Normal-vs-Stage4 |
3.032500E-02 |
| Stage1-vs-Stage2 |
3.036000E-02 |
| Stage1-vs-Stage3 |
3.867700E-02 |
| Stage1-vs-Stage4 |
8.135600E-01 |
| Stage2-vs-Stage3 |
3.508400E-01 |
| Stage2-vs-Stage4 |
6.063500E-02 |
| Stage3-vs-Stage4 |
1.361570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.219500E-02 |
| Normal-vs-AfricanAmerican |
5.021400E-01 |
| Normal-vs-Asian |
8.055800E-02 |
| Caucasian-vs-AfricanAmerican |
3.384000E-01 |
| Caucasian-vs-Asian |
5.074400E-01 |
| AfricanAmerican-vs-Asian |
3.213800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.682400E-02 |
| Normal-vs-Female |
1.601880E-03 |
| Male-vs-Female |
6.035700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.029010E-01 |
| Normal-vs-Age(41-60Yrs) |
5.875900E-03 |
| Normal-vs-Age(61-80Yrs) |
8.160000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.559200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.611400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.589400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.231830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.982850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.188240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.597400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.511770E-02 |
| Normal-vs-Grade 2 |
1.176420E-02 |
| Normal-vs-Grade 3 |
1.902770E-01 |
| Normal-vs-Grade 4 |
4.656200E-02 |
| Grade 1-vs-Grade 2 |
3.633600E-01 |
| Grade 1-vs-Grade 3 |
1.785990E-01 |
| Grade 1-vs-Grade 4 |
5.212400E-01 |
| Grade 2-vs-Grade 3 |
1.879840E-01 |
| Grade 2-vs-Grade 4 |
7.622800E-01 |
| Grade 3-vs-Grade 4 |
2.333000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.877000E-01 |
| Normal-vs-ccB subtype |
4.983300E-03 |
| ccA subtype-vs-ccB subtype |
2.636300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.435200E-03 |
| Normal-vs-N1 |
4.470200E-01 |
| N0-vs-N1 |
8.096800E-01 |
|
|
